Genetically engineered murine models of prostate cancer: Insights into mechanisms of tumorigenesis and potential utility

Sarki A. Abdulkadir*, Jongchan Kim

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

There has been substantial progress made recently in the effort to model human prostate cancer in mice. Several mutant mice have been generated which mimic various aspects of the human disease, including the development of preneoplastic lesions, invasive carcinoma, and metastases. These mouse reagents provide the research community with valuable new tools for dissecting the mechanisms of tumorigenesis, as well as for testing new targeted therapies. This review will summarize some of these models and their utility, as well as propose future challenges for developing improved models.

Original languageEnglish (US)
Pages (from-to)351-360
Number of pages10
JournalFuture Oncology
Volume1
Issue number3
DOIs
StatePublished - Jun 1 2005

Keywords

  • androgen
  • chemoprevention
  • haploinsufficiency
  • prostate cancer
  • rostatic intraepithelial neoplasia
  • therapy
  • transgenic mice
  • tumor suppressor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Genetically engineered murine models of prostate cancer: Insights into mechanisms of tumorigenesis and potential utility'. Together they form a unique fingerprint.

Cite this